## Abstract ## BACKGROUND Malignant tumors of the skull base are rare. Therefore, no single center treats enough patients to accumulate significant numbers for meaningful analysis of outcomes after craniofacial surgery (CFS). The current report was based on a large cohort that was analyzed retrosp
โฆ LIBER โฆ
86 Proton treatment for pediatric intracranial and base of skull tumors, a preliminary report
โ Scribed by Bruce McAllister; M. Connie Nguyen; John Archambeau; Lilia Loredo; Jerry D. Slater; Reinhard Shulte; Ofelia Alvarez; Antranik A. Bedros; Thomas Kaleita; Michael Moyers; Dan Miller; James Slater
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 96 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Craniofacial surgery for malignant skull
โ
Snehal G. Patel; Bhuvanesh Singh; Ashok Polluri; Patrick G. Bridger; Giulio Cant
๐
Article
๐
2003
๐
John Wiley and Sons
๐
English
โ 93 KB
๐ 2 views
A dose-intensive, cyclophosphamide-based
โ
Paul A. Carpenter; Les White; Geoffrey B. McCowage; Vimala Nayanar; Ian Toogood;
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 130 KB
๐ 3 views
promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.
Rosito P, Mancini AF, Rondelli R, et al.
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 22 KB
๐ 2 views